Donald Francis Sinex
Direktor/Vorstandsmitglied bei Gold Avenue Ltd.
Profil
Mr. Donald F.
Sinex is Independent Director at Immtech Pharmaceuticals, Inc. He is on the Board of Directors at Gold Avenue Ltd.
and Immtech Pharmaceuticals, Inc.
He received his undergraduate degree from the University of Delaware, a graduate degree from the University of Miami (Florida), and an MBA from Harvard University.
Aktive Positionen von Donald Francis Sinex
| Unternehmen | Position | Beginn |
|---|---|---|
Gold Avenue Ltd.
 Gold Avenue Ltd. Other Metals/MineralsNon-Energy Minerals Gold Avenue Ltd. is an investment holding Chinese company that is primarily focused on the production and sale of tin. | Direktor/Vorstandsmitglied | 30.11.2009 |
Ehemalige bekannte Positionen von Donald Francis Sinex
| Unternehmen | Position | Ende |
|---|---|---|
Immtech Pharmaceuticals, Inc.
 Immtech Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Immtech Pharmaceuticals, Inc. develops and distributes pharmaceuticals. The company's efforts reflect extensive work in clinical research, new product development and marketing. The company focuses on developing a new treatment for the Hepatitis C virus. Immtech Pharmaceuticals was founded on October 15, 1984 and is headquartered in New York, NY. | Direktor/Vorstandsmitglied | - |
Ausbildung von Donald Francis Sinex
| Harvard University | Masters Business Admin |
| University of Delaware | Undergraduate Degree |
| University of Miami | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Immtech Pharmaceuticals, Inc.
Immtech Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Immtech Pharmaceuticals, Inc. develops and distributes pharmaceuticals. The company's efforts reflect extensive work in clinical research, new product development and marketing. The company focuses on developing a new treatment for the Hepatitis C virus. Immtech Pharmaceuticals was founded on October 15, 1984 and is headquartered in New York, NY. | Health Technology |
Gold Avenue Ltd.
Gold Avenue Ltd. Other Metals/MineralsNon-Energy Minerals Gold Avenue Ltd. is an investment holding Chinese company that is primarily focused on the production and sale of tin. | Non-Energy Minerals |
